Sfoglia per RIVISTA
THE LANCET. HAEMATOLOGY
Collezione AOU Alessandria

  

Items : 10

Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes. in The Lancet. Haematology / Lancet Haematol. 2024 Nov;11(11):e862-e872. doi: 10.1016/S2352-3026(24)00251-5. Epub 2024 Oct 9.

2024
AOU Alessandria

Komrokji RS; Lanino L; Ball S; Bewersdorf JP; Marchetti M; Maggioni G; Travaglino E; Al Ali NH; Fenaux P; Platzbecker U; Santini V; Diez-Campelo M; Singh A; Jain AG; Aguirre LE; Tinsley-Vance SM; Schwabkey ZI; Chan O; Xie Z; Brunner AM; Kuykendall AT; Bennett JM; Buckstein R; Bejar R; Carraway HE; DeZern AE; Griffiths EA; Halene S; Hasserjian RP; et alii...

Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2024 Jul;11(7):e499-e509. doi: 10.1016/S2352-3026(24)00143-1.

2024
AOU Città della Salute di Torino
AOU Alessandria

Galimberti S; Ladetto M; Foà R; Del Giudice I; Ricardi U; Gattei V; Arcaini L; Della Starza I; Drandi D; Genuardi E; Ciabatti E; Bomben R; De Novi LA; Cavalli M; Guarini A; Grapulin L; Assanto GM; Annechini G; Celli M; Tani M; Mannina D; Re F; Cencini E; Mannarella C; Bigliardi S; Tucci A; Corradini P; Perrone T; Stelitano C; et alii...

Appropriate management of polycythaemia vera with cytoreductive drug therapy: European LeukemiaNet 2021 recommendations. in The Lancet. Haematology / Lancet Haematol. 2022 Apr;9(4):e301-e311. doi: 10.1016/S2352-3026(22)00046-1.

2022
AOU Alessandria

Kiladjian JJ; Silver RT; Passamonti F; Barosi G; Guglielmelli P; Palandri F; De Stefano V; Álvarez-Larrán A; Harrison C; Gisslinger H; Koschmieder S; Griesshammer M; Marchetti M; Vannucchi AM; Hehlmann R; Barbui T;

The role of autologous haematopoietic stem-cell transplantation in mantle cell lymphoma. in The Lancet. Haematology / Lancet Haematol. 2021 Sep;8(9):e617-e619. doi: 10.1016/S2352-3026(21)00237-4.

2021
AOU Alessandria

Ladetto M; Chiappella A;

Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial. in The Lancet. Haematology

2021
AOU Alessandria
AOU Città della Salute di Torino

Martelli M; Stelitano C; Vitolo U; Ciccone G; Casaroli I; Narni F; Stefani PM; Benedetti F; Molinari AL; Ballerini F; Puccini B; Ferreri AJM; Gomes da Silva M; Arcaini L; Balzarotti M; Zilioli VR; Chiappella A; Re A; Di Rocco A; Pagani C; Stefoni V; Cavallo F; Zanni M; Tavarozzi R; Mian M; Ferrero S; Evangelista A; Cortelazzo S; Ladetto M; et alii...

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. in The Lancet. Haematology / Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.

2020
AOU Alessandria
ASL Biella
AOU Città della Salute di Torino
ASL Torino 5
AOU Novara

Grossi PA; Corradini P; Pagano L; Corrao G; Bertù L; Franchi M; Visco C; Rigacci L; Armiento D; Pane F; Oberti M; Zappasodi P; Galieni P; Fava C; Candoni A; Venditti A; Pinto A; Marchesi F; Musto P; Federici AB; Olivieri A; Gentile M; Bocchia M; Selleri C; Ortu La Barbera E; Ferrandina C; Di Renzo N; Luppi M; Scattolin AM; et alii...

Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. in The Lancet. Haematology / Lancet Haematol. 2020 Feb;7(2):e157-e167. doi: 10.1016/S2352-3026(19)30256-X.

2020
AOU Alessandria

Penack O; Marchetti M; Ruutu T; Aljurf M; Bacigalupo A; Bonifazi F; Ciceri F; Cornelissen J; Malladi R; Duarte RF; Giebel S; Greinix H; Holler E; Lawitschka A; Mielke S; Mohty M; Arat M; Nagler A; Passweg J; Schoemans H; Socié G; Solano C; Vrhovac R; Zeiser R; Kröger N; Basak GW;

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2017 Nov;4(11):e510-e523. doi: 10.1016/S2352-3026(17)30174-6. Epub 2017 Oct 17.

2017
AOU Città della Salute di Torino
AOU Alessandria

Deckert M; Ponzoni M; Angrilli F; Cabras G; Pfreundschuh M; Rummel M; Smith J; Hertenstein B; Schmoll HJ; Krause SW; Levis A; Pisani F; Orsucci L; Tucci A; Panse J; Stilgenbauer S; Keller U; Hess G; Balzarotti M; Sønderskov Gørløv J; Pukrop T; Linton KM; Johnson P; Hemmaway C; Roth A; Ambrosetti A; Ilariucci F; Falautano M; Politi LS; et alii...

Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial. in The Lancet. Haematology / Lancet Haematol. 2017 Mar;4(3):e127-e136. doi: 10.1016/S2352-3026(17)30012-1. Epub 2017 Feb 3.

2017
AOU Alessandria

Oliva EN; Alati C; Santini V; Poloni A; Molteni A; Niscola P; Salvi F; Sanpaolo G; Balleari E; Germing U; Fenaux P; Stamatoullas A; Palumbo GA; Salutari P; Impera S; Avanzini P; Cortelezzi A; Liberati AM; Carluccio P; Buccisano F; Voso MT; Mancini S; Kulasekararaj A; Morabito F; Bocchia M; Cufari P; Spiriti MA; Santacaterina I; D'Errigo MG; et alii...

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2016 May;3(5):e217-27. doi: 10.1016/S2352-3026(16)00036-3. Epub 2016 Apr 6.

2016
AOU Città della Salute di Torino
AOU Alessandria

Reni M; Finke J; Cavalli F; Schmoll HJ; Levis A; Krause SW; Keller U; Hertenstein B; Stilgenbauer S; Tucci A; Pisani F; Panse J; Hess G; Gørløv JS; Johnson P; Fabbri A; Balzarotti M; Pukrop T; Binder M; Rudà R; Linton KM; Ferrari A; Hemmaway C; Roth A; Ambrosetti A; Schorb E; Rosée PL; Fox CP; Illerhaus G; et alii...